View Older Stories View More Recent Stories

Jun 24, 2016 09:00AM Pfizer Completes Acquisition of Anacor
Jun 23, 2016 04:00PM Pfizer Declares 30-Cent Third-Quarter 2016 Dividend
Jun 20, 2016 08:11AM Pfizer (PFE) Selects Oracle's (ORCL) Cloud Services for Clinical Data Management
Jun 16, 2016 09:00AM Help Pfizer Change The Future Of Healthy Aging
Jun 16, 2016 08:30AM Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts
Jun 13, 2016 06:25AM Pfizer (PFE) Announces Publication of Final Phase 3 INO-VATE ALL Data; PFS Improvement Noted
Jun 12, 2016 05:15AM Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Jun 11, 2016 11:00AM Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2 Inhibitor, Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes
Jun 9, 2016 07:30AM Pro Golfer Jim Furyk Teams Up With Pfizer To Raise Awareness For Pneumococcal Pneumonia And The Importance Of Older Adult Vaccination
Jun 8, 2016 07:15PM Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules for Approval
Jun 8, 2016 07:01AM Pfizer Research Advances Body Of Evidence For Tofacitinib Citrate (XELJANZ®) Providing Clinicians With Additional Information For The Treatment Of Moderate to Severe RA
Jun 7, 2016 07:01AM Pfizer (PFE) Announces Positive Top-Line XELJANZ Phase 3 Data in PsA
Jun 7, 2016 07:00AM Pfizer Announces Positive Top-Line Results from Second Phase 3 Trial of Oral XELJANZ® (Tofacitinib Citrate) in Adults with Psoriatic Arthritis
Jun 6, 2016 09:00AM ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
Jun 6, 2016 09:00AM ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
Jun 6, 2016 08:09AM Pfizer (PFE) Announces Positive Lorlatinib Phase 1/2 Data in NSCLC; Positive Response Noted
Jun 6, 2016 08:00AM Pfizer Presents Promising Data from Next Generation ALK/ROS1 Inhibitor in Advanced Non-Small Cell Lung Cancer
Jun 6, 2016 06:37AM Pfizer (PFE) Announces Encouraging Safety Data from Utomilumab Combo Phase 1b in Adv. Solid Tumors
Jun 4, 2016 08:00AM Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor
May 31, 2016 07:05PM Pfizer Prices $5.0 Billion Debt Offering
May 23, 2016 07:00AM CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP
May 20, 2016 08:01AM Pfizer (PFE) Announces EMA Acceptance of TRUMENBA Marketing App
May 20, 2016 08:00AM Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)
May 20, 2016 06:00AM On BizWireTV: Streaming Service Finds Television and Climate Change on the Radar
May 19, 2016 08:30AM Hospira Launches LifeCare PCA® 7.0 Infusion System, First PCA Pump That Integrates with the Electronic Medical Record
May 19, 2016 06:31AM Spark Therapeutics (ONCE), Pfizer (PFE) to Present Encouraging SPK-9001 Data at EHA Congress
May 19, 2016 06:30AM Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therapeutic Levels of Factor IX Expression
May 18, 2016 05:30PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:30PM Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:08PM Pfizer (PFE) to Showcase Diverse and Growing Oncology Portfolio at ASCO
May 18, 2016 05:00PM Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
May 17, 2016 08:00AM Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)
May 16, 2016 06:46AM Pfizer (PFE) to Acquire Anacor Pharmaceuticals (ANAC) in $5.2B Deal
May 16, 2016 06:45AM Pfizer to Acquire Anacor
May 11, 2016 08:00AM Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative
May 5, 2016 07:01AM WAVE Life Sciences Enters Collaboration with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases
Apr 28, 2016 12:00PM Pfizer Hosts Annual Meeting of Shareholders
Apr 26, 2016 08:30AM Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
Apr 25, 2016 06:26AM Pfizer (PFE) Announces Publication of Data from Largest Smoking Cessation Medicines Trial
Apr 22, 2016 06:30PM CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet
Apr 19, 2016 08:00AM Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)
Apr 15, 2016 06:00AM On the Latest BizWireTV Cars Get Night Vision and Healthy Eating Made More Accessible
Apr 7, 2016 08:30AM Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care
Apr 6, 2016 11:08AM Pfizer (PFE) Receives EMA CHMP Approval for MDV Presentation of Prevenar 13
Apr 6, 2016 11:00AM Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
Apr 6, 2016 06:45AM Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)
Apr 6, 2016 06:45AM Pfizer Announces Termination of Proposed Combination with Allergan
Apr 5, 2016 05:35PM Pfizer (PFE) Announces FDA Approval for INFLECTRA (Biosimilar Infliximab)
Apr 5, 2016 05:34PM FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications
Apr 5, 2016 09:26AM Pre-Open Stock Movers 04/05: (VRX) (MRVL) (ICPT) Higher; (PSUN) (AGN) (NATI) Lower (more...)
View More Recent Stories View Older Stories